| Dr Randy Cox, OD | |
|
201 E Parker Mckenzie Drive, Anadarko, OK 73005 | |
| (405) 247-7945 | |
| (405) 247-7991 |
| Full Name | Dr Randy Cox |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 201 E Parker Mckenzie Drive, Anadarko, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467939249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT-002387 (Arizona) | Secondary |
| 152W00000X | Optometrist | 2974 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawton Indian Hospital | Lawton, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carnegie Indian Health Center | 1456456144 | 5 |
| Lawton Indian Hospital | 6406800234 | 94 |
| Anadarko Indian Health Center | 7719931559 | 39 |
News Archive
Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.
Research on bullying, firearms, ADHD, safe sleep, obesity, autism, vaccine hesitancy and other pediatric topics will be presented in Vancouver, British Columbia, May 3-6 at the Pediatric Academic Societies and Asian Society for Pediatric Research 2014 Joint Meeting, the largest international meeting focused on research in child health.
Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Evotec AG today announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of Education and Research (BMBF) to advance its H3 receptor antagonist programme into the clinic.
› Verified 7 days ago
| Provider Name | Winslow Indian Health Care Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184729493 PECOS PAC ID: 4284548991 Enrollment ID: O20031117000864 |
News Archive
Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.
Research on bullying, firearms, ADHD, safe sleep, obesity, autism, vaccine hesitancy and other pediatric topics will be presented in Vancouver, British Columbia, May 3-6 at the Pediatric Academic Societies and Asian Society for Pediatric Research 2014 Joint Meeting, the largest international meeting focused on research in child health.
Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Evotec AG today announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of Education and Research (BMBF) to advance its H3 receptor antagonist programme into the clinic.
› Verified 7 days ago
| Provider Name | Lawton Indian Hospital |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1760489223 PECOS PAC ID: 6406800234 Enrollment ID: O20050304000301 |
News Archive
Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.
Research on bullying, firearms, ADHD, safe sleep, obesity, autism, vaccine hesitancy and other pediatric topics will be presented in Vancouver, British Columbia, May 3-6 at the Pediatric Academic Societies and Asian Society for Pediatric Research 2014 Joint Meeting, the largest international meeting focused on research in child health.
Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Evotec AG today announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of Education and Research (BMBF) to advance its H3 receptor antagonist programme into the clinic.
› Verified 7 days ago
| Provider Name | Anadarko Indian Health Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881637403 PECOS PAC ID: 7719931559 Enrollment ID: O20050304000365 |
News Archive
Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.
Research on bullying, firearms, ADHD, safe sleep, obesity, autism, vaccine hesitancy and other pediatric topics will be presented in Vancouver, British Columbia, May 3-6 at the Pediatric Academic Societies and Asian Society for Pediatric Research 2014 Joint Meeting, the largest international meeting focused on research in child health.
Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Evotec AG today announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of Education and Research (BMBF) to advance its H3 receptor antagonist programme into the clinic.
› Verified 7 days ago
| Provider Name | Carnegie Indian Health Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457459158 PECOS PAC ID: 1456456144 Enrollment ID: O20071217000184 |
News Archive
Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.
Research on bullying, firearms, ADHD, safe sleep, obesity, autism, vaccine hesitancy and other pediatric topics will be presented in Vancouver, British Columbia, May 3-6 at the Pediatric Academic Societies and Asian Society for Pediatric Research 2014 Joint Meeting, the largest international meeting focused on research in child health.
Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Evotec AG today announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of Education and Research (BMBF) to advance its H3 receptor antagonist programme into the clinic.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Randy Cox, OD 1515 Ne Lawrie Tatum Rd, Lawton, OK 73507-3099 Ph: (405) 247-7944 | Dr Randy Cox, OD 201 E Parker Mckenzie Drive, Anadarko, OK 73005 Ph: (405) 247-7945 |
News Archive
Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.
Research on bullying, firearms, ADHD, safe sleep, obesity, autism, vaccine hesitancy and other pediatric topics will be presented in Vancouver, British Columbia, May 3-6 at the Pediatric Academic Societies and Asian Society for Pediatric Research 2014 Joint Meeting, the largest international meeting focused on research in child health.
Experts at Johns Hopkins and New York's Mount Sinai Health System have published a suggested new plan for a five-stage system of classifying the risk of heart attack in those with heart disease, one they say puts much-needed and long-absent focus on the risks faced by millions of Americans who pass so-called stress tests or have less obvious or earlier-stage danger signs.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
Evotec AG today announced that it will receive funding of up to EUR 1.5 million from the German Federal Ministry of Education and Research (BMBF) to advance its H3 receptor antagonist programme into the clinic.
› Verified 7 days ago
Dr. Gregory Dale Clift, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 115 N. E. Oldtown Dr, Anadarko, OK 73005 Phone: 405-247-2458 Fax: 405-247-6653 | |
Robert D Slavin, OD, INC. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 122 W Broadway St, Anadarko, OK 73005 Phone: 405-247-6412 Fax: 405-247-7129 | |
Cocheran Family Eye Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 802 W Petree Rd, Anadarko, OK 73005 Phone: 405-247-3937 | |
Robert D. Slavin O.d., Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 122 W Broadway St, Box 648, Anadarko, OK 73005 Phone: 405-247-6412 Fax: 405-247-7129 | |
Dr. Justin Cocheran, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 802 W Petree Rd, Anadarko, OK 73005 Phone: 405-326-3942 |